BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 290 filers reported holding BIONTECH SE in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,122 | -71.0% | 2,109 | -71.2% | 0.00% | -71.4% |
| Q2 2023 | $789,508 | -47.5% | 7,315 | -39.4% | 0.01% | -54.8% |
| Q1 2023 | $1,502,688 | +98.2% | 12,063 | +139.1% | 0.03% | +93.8% |
| Q4 2022 | $758,011 | -37.7% | 5,046 | -44.1% | 0.02% | -30.4% |
| Q3 2022 | $1,217,000 | -45.7% | 9,022 | -39.9% | 0.02% | -58.2% |
| Q2 2022 | $2,240,000 | -29.6% | 15,023 | -19.5% | 0.06% | -1.8% |
| Q1 2022 | $3,182,000 | +41.9% | 18,659 | +114.4% | 0.06% | +55.6% |
| Q4 2021 | $2,243,000 | -26.5% | 8,701 | -22.2% | 0.04% | -37.9% |
| Q3 2021 | $3,053,000 | +382.3% | 11,181 | +295.2% | 0.06% | +346.2% |
| Q2 2021 | $633,000 | +2160.7% | 2,829 | +1009.4% | 0.01% | +1200.0% |
| Q1 2021 | $28,000 | -89.5% | 255 | -92.2% | 0.00% | -88.9% |
| Q4 2020 | $266,000 | +141.8% | 3,255 | +73.6% | 0.01% | 0.0% |
| Q1 2020 | $110,000 | – | 1,875 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |